Research programme: anti-EGFR monoclonal antibodies - InNexus Biotechnology
Alternative Names: DXL 1218Latest Information Update: 16 Jul 2016
At a glance
- Originator InNexus Biotechnology
- Class Monoclonal antibodies
- Mechanism of Action Epidermal growth factor receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Colorectal cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Colorectal-cancer in Canada (Parenteral)
- 11 Nov 2008 Preclinical trials in Colorectal cancer in Canada (Parenteral)